


Traditionally, TEE intubation has been performed blind, meaning the physician cannot see the esophagus and surrounding structures during probe placement. Now with TEECAD, physicians can perform completely visual TEE intubations like endoscopists to guide critical cardiology procedures with greater safety and efficiency." "For decades, physicians have been adapting existing technologies to try and find a solution for blind TEE intubation. "The presentation of the clinical data from Mayo Clinic is an important milestone for Visura and real-time visualization for TEE procedures," said David Marmor, Cardiologist at Shaare Zedek Medical Center in Jerusalem, Israel and Founder of Visura Technologies. The TEECAD System is the world's first, FDA-cleared disposable camera that seamlessly connects to TEE probes to provide real-time visualization during intubation to support first pass success and reduce TEE procedural complications. In addition, Visura will release a new 15 patient TEECAD white paper from a world-renowned heart center.įirst ever clinical data on an innovation designed to advance TEE procedure will be presented at global meeting At this year's meeting, the TEECAD system will be highlighted in an abstract poster presentation by Sunil Mankad MD, Professor of Medicine, and Director of Transesophageal Echocardiography at the Mayo Clinic in Rochester, MN on Sunday, June 25 at 2:00 pm. MINNEAPOLIS, J/PRNewswire/ - Visura Technologies, Inc., a privately-held medical device company dedicated to delivering state-of-the-art visualization solutions to improve the safety and success of transesophageal echocardiogram (TEE) probe intubations, announced today it will be attending the American Society of Echocardiography's (ASE) 34 th Annual Scientific Sessions in Baltimore, MD June 23-26. First ever clinical data on an innovation specifically designed to advance the TEE procedure will be presented at global echocardiography meeting
